MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$5,158,932 Current assets ofdiscontinued operations$1,070,313 Prepaids and othercurrent assets$617,211 Short-term investments$41,625 Intangible assets$2,927,420 Total current assets$6,888,081 Intangible assets, net$1,498,473 Property, equipment androu assets, net$642,884 Other assets$104,368 Less accumulatedamortization$1,428,947 Total assets$9,133,806 Total liabilities andshareholders equity$9,133,806 Total shareholdersequity$6,891,774 Total liabilities$2,242,032 Accumulated deficit-$123,959,350 Common shares, no parvalue, unlimited...$92,578,071 Total currentliabilities$2,211,266 Lease obligations,net of current...$30,766 Additional paid-in capital$38,144,484 Accumulated othercomprehensive income$128,569 Accounts payable andaccrued liabilities$1,011,551 Current liabilities ofdiscontinued operations$810,334 Current portion of leaseobligations$389,381
Balance Sheet

InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Inc. (INM)

source: myfinsight.com